Last reviewed · How we verify
Electrochemotherapy
At a glance
| Generic name | Electrochemotherapy |
|---|---|
| Also known as | ECT |
| Sponsor | IGEA |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- An International Randomized Phase II Study Comparing Early Electrochemotherapy to Delayed or No Electrochemotherapy in Patients With Cutaneous Breast Cancer Metastases (Phase 2)
- Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study (NA)
- Electrochemotherapy of Gynecological Cancers (Phase 2)
- Registry on Percutaneous Electrochemotherapy (N/A)
- Electrochemotherapy in Musculoskeletal Tumors: A Quantitative Assessment of Tumor Size Variations and Treatment-related Pain Reduction. (N/A)
- Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial (Phase 1)
- Electrochemotherapy on Head and Neck Cancer (Phase 2)
- Treatment of Visceral Localizations With Electrochemotherapy in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype: Monocenter, Single Arm, Clinical Invest (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |